Wound Management Technologies has signed a letter of intent to acquire US-based medical device distributor Juventas.

Juventas products are used in surgical and non-surgical therapy, as well as in regenerative medicine.

Go deeper with GlobalData

Go deeper with GlobalData

The gold standard of business intelligence.

Find out more

Discover B2B Marketing That Performs

Combine business intelligence and editorial excellence to reach engaged professionals across 36 leading media platforms.

Find out more

As part of the agreement, Juventas principals Jeff Ott and Bryant Gaines will provide management services to Wound Management Technologies.

Gaines said the Juventas is currently evaluating additional core products to add to its portfolio for 2012, along with ancillary products to complement the existing products.

The acquisition includes an all-stock deal that will result in the owners of Juventas obtaining 12.5 million shares of Wound Management Technologies.

The transaction is subject to a number of conditions, and is expected to close by the first quarter of 2012.

GlobalData Strategic Intelligence

US Tariffs are shifting - will you react or anticipate?

Don’t let policy changes catch you off guard. Stay proactive with real-time data and expert analysis.

By GlobalData

Medical Device Network Excellence Awards - Nominations Closed

Nominations are now closed for the Medical Device Network Excellence Awards. A big thanks to all the organisations that entered – your response has been outstanding, showcasing exceptional innovation, leadership, and impact

Excellence in Action
Awarded for Innovation in Remote Hearing Diagnostics , hearX’s Self Test Kit (STK) delivers clinically validated audiometry via smart devices, enabling remote, scalable hearing assessments in homes, clinics and retail. Learn how hearX is redefining hearing care delivery and reducing costs for providers globally.

Discover the Impact